glp-1 new hope agonists for opioid use disorder: a hope? | Brittany Albright MD, MPH, DABOM posted on the topic Your GLP-1 journey deserves support

What PTs Should Monitor We encourage PTs to track the following during the BPC-157 program: Pain levels (at rest, with motion, and with loading) ROM and mobility progression Tissue tolerance to loading Swelling or inflammation patterns Strength development Neuromuscular control Return-to-function benchmarks Any unusual or unexpected symptoms If something seems off, PTs are encouraged to reach out to Thrive directly.

Calories Out

Hormonal fluctuations: Given DSIP's effects on LH and GH, some hormonal variability is possible, though rarely problematic in documented use

The ITP syndrome: pathogenic and clinical diversity